Ben Rains dives into the broader bullish case for the stock market in 2022. The focus then shifts to three highly-ranked cheap stocks from three totally different sectors of the economy trading for under $30 a share that investors might want to consider buying to start the new year. (0:30) – Stock Market Update: Everything
The concept of “sell in May and go away” is ringing true, but you can still benefit by advantaging broader market circumstances. Murphy USA (MUSA): The one name on this list of great growth stocks to buy that’s still killing it, the wages of war may continue to bolster MUSA. Alphabet (GOOG, GOOGL): Though suffering
Aterian (NASDAQ:ATER) released its first-quarter report on Monday, in which it revealed an earnings miss of 52 cents per share and a revenue shortfall of $1.14 million. This really shouldn’t come as a surprise, and I believe ATER stock is headed for another downward spiral. Much has been made of Aterian’s business model. However, I
Palantir Technologies (NYSE:PLTR) stock plunged 21.31% making a new 52-week low of $7.32 closing at $7.46 on May 9. This steep selloff was fueled by a heavy volume of nearly 3.5 times the average daily volume. The reason for this selloff was the first-quarter 2022 earnings announcement. Were these Q1 2022 earnings that bad? Shares
Take a look at some of the biggest movers in the premarket: Peloton (PTON) – Peloton shares plunged 25.8% in the premarket after the fitness equipment maker reported a larger-than-expected quarterly loss and projected current-quarter revenue below estimates due to softening demand. Novavax (NVAX) – Novavax sank 23% in premarket trading after the vaccine maker
Free markets are often conceptualized as having little to no interference from the government. However, in reality governments do step in to stabilize markets, regulate transactions, provide institutional frameworks, and enforce rules around contract law and property rights. Governments can also intervene when markets fail in the form of bailouts and other emergency measures. In
Twitter (TWTR) stock is still selling for $5/share less than Elon Musk’s offer. Musk has the money lined up thanks to SpaceX. What happens after the purchase isn’t your problem. Source: rafapress / Shutterstock.com Since Elon Musk said he would buy Twitter (NYSE:TWTR) for $54.20/share, about $44 billion, shares haven’t traded over $52. Twitter opened
Nio (NIO) offers Tesla (TSLA) luxury without the production volumes. The company has stiff competition within China, and those competitors are now exporting. Nio will likely remain small, and investors should demand a profit. Source: Robert Way / Shutterstock.com At this point in the game, investing in Nio (NYSE:NIO) stock means investing in the Chinese
Novavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated, demand for Novavax’s vaccine is likely to be weak. Rival pharmaceutical companies Pfizer and Moderna have beat Novavax to market with multiple Covid-19 treatments. Source: rarrarorro / Shutterstock.com Any hope
Traders work on the floor of the New York Stock Exchange (NYSE) in New York, May 9, 2022. Brendan McDermid | Reuters Goldman Sachs is scaling back its business in the once red-hot SPACs as blank-check deals got caught in a double whammy of regulatory crackdown and tough market environment. “We are reducing our involvement
U.S. stock futures were higher on Monday night after the S&P 500 fell to its lowest point in more than a year. Dow Jones Industrial Average futures rose by 105 points, or 0.4%. S&P 500 and Nasdaq 100 futures climbed 0.4% and 0.4%, respectively. Shares of AMC and Novavax made major moves after hours on
Biotech stocks are rallying this month.
Tech giant Nvidia (NASDAQ:NVDA) is set to report quarterly earnings on May 25 and the stock certainly hasn’t had a smooth ride this year. NVDA stock was once trading at the highs of $346 last year but has consistently dropped since the beginning of 2022. The stock is down more than 40% over the past
Nike (NYSE:NKE) posted lukewarm results for the quarter ending Feb. 28 with sales up just 5% year-over-year (YOY). It’s likely this quarter ending May 31 could show even worse results. We won’t know until late June or early July. The problem is investors in NKE stock likely won’t wait — they will sell first and
Rivian Automotive (NASDAQ:RIVN) shares are down more than 14% in Monday’s pre-market trading. The electric vehicle (EV) maker’s stock price is falling on the news that Ford (NYSE:F) is selling eight million of the 102 million Rivian shares it owns. Some speculation suggests Amazon (NASDAQ:AMZN) — which holds approximately 158 million shares (18%) — could
Take a look at some of the biggest movers in the premarket: Palantir Technologies (PLTR) – The data analytics software company’s shares plunged 15.1% in premarket trading after posting a mixed quarter. Palantir reported profit of 2 cents per share, compared to a 4 cents a share consensus estimate. Revenue was higher than expected, however,
The volatility surface is a three-dimensional plot showing the implied volatilities of a stock’s options that are listed on it across different strike prices and expirations. Not all options on the same stock have the same implied volatility (IV). These differences exist due to discrepancies in how the market prices stock options with different characteristics
Global conflict and rising interest rates in the U.S. are creating undervalued bank stocks. Citigroup (C) is in the news this week for a snafu in Europe, but that shouldn’t hurt C stock in the long-term. JPMorgan Chase & Co. (JPM) is the largest of the U.S. big bank stocks. Bank of America (BAC) had
Medical health services company Teladoc Health (NYSE:TDOC) has seen its prognosis go from bad to worse over the past month. TDOC stock had already plunged as part of the broader selloff in speculative technology companies. However, that selloff accelerated dramatically following Teladoc’s latest earnings report, which was a disappointment on almost all fronts. The terrible
The S&P 500 has been getting pummeled. That goes for the index, the S&P futures (ES) and the SPDR S&P 500 ETF (NYSEARCA:SPY). SPY stock is not the worst performer of the major U.S. indices, though. The Nasdaq is, barely edging out the Russell 2000, with its 26% decline. SPY is down about 15% from